nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—lung cancer	0.347	1	CiPCiCtD
Clofarabine—RRM1—lung cancer	0.16	0.797	CbGaD
Clofarabine—DCK—Pemetrexed—lung cancer	0.0551	0.242	CbGbCtD
Clofarabine—Cytarabine—Gemcitabine—lung cancer	0.0455	0.35	CrCrCtD
Clofarabine—Azacitidine—Gemcitabine—lung cancer	0.0432	0.333	CrCrCtD
Clofarabine—Decitabine—Gemcitabine—lung cancer	0.0412	0.317	CrCrCtD
Clofarabine—ABCG2—lung cancer	0.0407	0.203	CbGaD
Clofarabine—RRM2—Gemcitabine—lung cancer	0.0373	0.164	CbGbCtD
Clofarabine—RRM1—Gemcitabine—lung cancer	0.0373	0.164	CbGbCtD
Clofarabine—POLA1—Gemcitabine—lung cancer	0.0322	0.141	CbGbCtD
Clofarabine—DCK—Gemcitabine—lung cancer	0.0198	0.087	CbGbCtD
Clofarabine—ABCG2—Topotecan—lung cancer	0.00772	0.0338	CbGbCtD
Clofarabine—ABCG2—Gefitinib—lung cancer	0.00706	0.0309	CbGbCtD
Clofarabine—ABCG2—Teniposide—lung cancer	0.00684	0.03	CbGbCtD
Clofarabine—ABCG2—Erlotinib—lung cancer	0.00417	0.0183	CbGbCtD
Clofarabine—ABCG2—Paclitaxel—lung cancer	0.00382	0.0168	CbGbCtD
Clofarabine—ABCG2—Irinotecan—lung cancer	0.00377	0.0165	CbGbCtD
Clofarabine—ABCG2—Cisplatin—lung cancer	0.00307	0.0135	CbGbCtD
Clofarabine—ABCG2—Etoposide—lung cancer	0.00302	0.0132	CbGbCtD
Clofarabine—ABCG2—Docetaxel—lung cancer	0.00276	0.0121	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—lung cancer	0.00206	0.00903	CbGbCtD
Clofarabine—ABCG2—Methotrexate—lung cancer	0.00199	0.00875	CbGbCtD
Clofarabine—POLA1—mammary gland—lung cancer	0.0011	0.102	CbGeAlD
Clofarabine—RRM2—mammary gland—lung cancer	0.00105	0.0972	CbGeAlD
Clofarabine—RRM1—mammary gland—lung cancer	0.00087	0.0808	CbGeAlD
Clofarabine—RRM2—respiratory system—lung cancer	0.000698	0.0648	CbGeAlD
Clofarabine—RRM1—respiratory system—lung cancer	0.00058	0.0538	CbGeAlD
Clofarabine—RRM2—bronchus—lung cancer	0.000575	0.0533	CbGeAlD
Clofarabine—RRM1—bronchus—lung cancer	0.000477	0.0443	CbGeAlD
Clofarabine—Adenosine monophosphate—ADCY1—lung cancer	0.000455	0.371	CrCbGaD
Clofarabine—POLA1—bone marrow—lung cancer	0.000428	0.0397	CbGeAlD
Clofarabine—RRM2—bone marrow—lung cancer	0.000409	0.038	CbGeAlD
Clofarabine—RRM1—cardiac atrium—lung cancer	0.000403	0.0374	CbGeAlD
Clofarabine—POLA1—lung—lung cancer	0.000388	0.036	CbGeAlD
Clofarabine—DCK—bronchus—lung cancer	0.000371	0.0344	CbGeAlD
Clofarabine—RRM2—lung—lung cancer	0.000371	0.0344	CbGeAlD
Clofarabine—Fludarabine—RRM1—lung cancer	0.000349	0.285	CrCbGaD
Clofarabine—RRM1—bone marrow—lung cancer	0.00034	0.0315	CbGeAlD
Clofarabine—DCK—trachea—lung cancer	0.000333	0.0309	CbGeAlD
Clofarabine—DCK—cardiac atrium—lung cancer	0.000313	0.029	CbGeAlD
Clofarabine—RRM1—lung—lung cancer	0.000308	0.0286	CbGeAlD
Clofarabine—POLA1—lymph node—lung cancer	0.000265	0.0246	CbGeAlD
Clofarabine—DCK—bone marrow—lung cancer	0.000264	0.0245	CbGeAlD
Clofarabine—RRM2—lymph node—lung cancer	0.000254	0.0235	CbGeAlD
Clofarabine—DCK—lung—lung cancer	0.000239	0.0222	CbGeAlD
Clofarabine—RRM2—Afatinib—Gefitinib—lung cancer	0.000227	0.196	CbGdCrCtD
Clofarabine—RRM2—Gefitinib—Erlotinib—lung cancer	0.000223	0.192	CbGdCrCtD
Clofarabine—RRM1—lymph node—lung cancer	0.000211	0.0195	CbGeAlD
Clofarabine—Cladribine—RRM1—lung cancer	0.000207	0.169	CrCbGaD
Clofarabine—DCK—Topotecan—Irinotecan—lung cancer	0.000188	0.162	CbGdCrCtD
Clofarabine—POLA1—Vinblastine—Vinorelbine—lung cancer	0.000177	0.152	CbGdCrCtD
Clofarabine—DCK—lymph node—lung cancer	0.000164	0.0152	CbGeAlD
Clofarabine—RRM2—Vinorelbine—Vinblastine—lung cancer	0.000149	0.129	CbGdCrCtD
Clofarabine—ABCG2—bone marrow—lung cancer	0.000147	0.0137	CbGeAlD
Clofarabine—ABCG2—lung—lung cancer	0.000133	0.0124	CbGeAlD
Clofarabine—Adenosine monophosphate—SRC—lung cancer	0.000106	0.086	CrCbGaD
Clofarabine—RRM1—Azacitidine—Gemcitabine—lung cancer	9.57e-05	0.0825	CbGdCrCtD
Clofarabine—ABCG2—lymph node—lung cancer	9.13e-05	0.00847	CbGeAlD
Clofarabine—RRM2—Azacitidine—Gemcitabine—lung cancer	6.01e-05	0.0518	CbGdCrCtD
Clofarabine—S-Adenosylmethionine—CYP2E1—lung cancer	5.78e-05	0.0471	CrCbGaD
Clofarabine—Cladribine—ABCG2—lung cancer	5.29e-05	0.0431	CrCbGaD
Clofarabine—DCK—Epirubicin—Doxorubicin—lung cancer	4.08e-05	0.0352	CbGdCrCtD
Clofarabine—Infestation NOS—Methotrexate—lung cancer	1.82e-05	0.00033	CcSEcCtD
Clofarabine—Infestation—Methotrexate—lung cancer	1.82e-05	0.00033	CcSEcCtD
Clofarabine—Anorexia—Paclitaxel—lung cancer	1.81e-05	0.000328	CcSEcCtD
Clofarabine—Hypotension—Etoposide—lung cancer	1.81e-05	0.000328	CcSEcCtD
Clofarabine—Pain—Cisplatin—lung cancer	1.81e-05	0.000328	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Methotrexate—lung cancer	1.81e-05	0.000327	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Doxorubicin—lung cancer	1.81e-05	0.000327	CcSEcCtD
Clofarabine—Vomiting—Vinorelbine—lung cancer	1.8e-05	0.000326	CcSEcCtD
Clofarabine—RRM2—Metabolism—B4GALT5—lung cancer	1.8e-05	0.000692	CbGpPWpGaD
Clofarabine—Body temperature increased—Gemcitabine—lung cancer	1.8e-05	0.000325	CcSEcCtD
Clofarabine—Renal failure—Methotrexate—lung cancer	1.79e-05	0.000324	CcSEcCtD
Clofarabine—RRM1—Metabolism—GNG11—lung cancer	1.79e-05	0.000689	CbGpPWpGaD
Clofarabine—DCK—Metabolism—RRM1—lung cancer	1.79e-05	0.000688	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTA3—lung cancer	1.79e-05	0.000688	CbGpPWpGaD
Clofarabine—Rash—Vinorelbine—lung cancer	1.78e-05	0.000323	CcSEcCtD
Clofarabine—Dermatitis—Vinorelbine—lung cancer	1.78e-05	0.000323	CcSEcCtD
Clofarabine—Hypotension—Paclitaxel—lung cancer	1.78e-05	0.000322	CcSEcCtD
Clofarabine—Stomatitis—Methotrexate—lung cancer	1.78e-05	0.000322	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—EP300—lung cancer	1.77e-05	0.000682	CbGpPWpGaD
Clofarabine—Headache—Vinorelbine—lung cancer	1.77e-05	0.000321	CcSEcCtD
Clofarabine—Influenza—Doxorubicin—lung cancer	1.77e-05	0.00032	CcSEcCtD
Clofarabine—Leukopenia—Docetaxel—lung cancer	1.77e-05	0.00032	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.76e-05	0.000677	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTA4—lung cancer	1.75e-05	0.000673	CbGpPWpGaD
Clofarabine—Feeling abnormal—Cisplatin—lung cancer	1.75e-05	0.000316	CcSEcCtD
Clofarabine—Paraesthesia—Etoposide—lung cancer	1.74e-05	0.000315	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—lung cancer	1.74e-05	0.000669	CbGpPWpGaD
Clofarabine—Haematuria—Methotrexate—lung cancer	1.74e-05	0.000315	CcSEcCtD
Clofarabine—Pancreatitis—Doxorubicin—lung cancer	1.74e-05	0.000314	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Paclitaxel—lung cancer	1.73e-05	0.000314	CcSEcCtD
Clofarabine—Dyspnoea—Etoposide—lung cancer	1.73e-05	0.000313	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.73e-05	0.000665	CbGpPWpGaD
Clofarabine—Somnolence—Etoposide—lung cancer	1.73e-05	0.000312	CcSEcCtD
Clofarabine—Cough—Docetaxel—lung cancer	1.72e-05	0.000312	CcSEcCtD
Clofarabine—Hepatobiliary disease—Methotrexate—lung cancer	1.72e-05	0.000312	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.72e-05	0.000663	CbGpPWpGaD
Clofarabine—Epistaxis—Methotrexate—lung cancer	1.72e-05	0.000311	CcSEcCtD
Clofarabine—Hypersensitivity—Irinotecan—lung cancer	1.72e-05	0.000311	CcSEcCtD
Clofarabine—POLA1—S Phase—MYC—lung cancer	1.72e-05	0.000661	CbGpPWpGaD
Clofarabine—Paraesthesia—Paclitaxel—lung cancer	1.71e-05	0.000309	CcSEcCtD
Clofarabine—Hypertension—Docetaxel—lung cancer	1.71e-05	0.000309	CcSEcCtD
Clofarabine—RRM2—Metabolism—GSTA2—lung cancer	1.71e-05	0.000656	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALDOA—lung cancer	1.71e-05	0.000656	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.7e-05	0.000655	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—BIRC5—lung cancer	1.7e-05	0.000655	CbGpPWpGaD
Clofarabine—Dyspnoea—Paclitaxel—lung cancer	1.7e-05	0.000307	CcSEcCtD
Clofarabine—Somnolence—Paclitaxel—lung cancer	1.69e-05	0.000306	CcSEcCtD
Clofarabine—Decreased appetite—Etoposide—lung cancer	1.69e-05	0.000305	CcSEcCtD
Clofarabine—Arthralgia—Docetaxel—lung cancer	1.68e-05	0.000305	CcSEcCtD
Clofarabine—Myalgia—Docetaxel—lung cancer	1.68e-05	0.000305	CcSEcCtD
Clofarabine—Pancytopenia—Doxorubicin—lung cancer	1.68e-05	0.000304	CcSEcCtD
Clofarabine—DCK—Metabolism—B4GALT5—lung cancer	1.68e-05	0.000647	CbGpPWpGaD
Clofarabine—Nausea—Vinorelbine—lung cancer	1.68e-05	0.000304	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—lung cancer	1.68e-05	0.000646	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Etoposide—lung cancer	1.68e-05	0.000303	CcSEcCtD
Clofarabine—Body temperature increased—Cisplatin—lung cancer	1.67e-05	0.000303	CcSEcCtD
Clofarabine—Asthenia—Irinotecan—lung cancer	1.67e-05	0.000303	CcSEcCtD
Clofarabine—Fatigue—Etoposide—lung cancer	1.67e-05	0.000303	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	1.67e-05	0.000302	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.67e-05	0.000641	CbGpPWpGaD
Clofarabine—Pain—Etoposide—lung cancer	1.66e-05	0.0003	CcSEcCtD
Clofarabine—RRM1—Metabolism—NCOA3—lung cancer	1.66e-05	0.000637	CbGpPWpGaD
Clofarabine—Neutropenia—Doxorubicin—lung cancer	1.66e-05	0.0003	CcSEcCtD
Clofarabine—Decreased appetite—Paclitaxel—lung cancer	1.65e-05	0.000299	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TERT—lung cancer	1.65e-05	0.000634	CbGpPWpGaD
Clofarabine—Upper respiratory tract infection—Doxorubicin—lung cancer	1.65e-05	0.000298	CcSEcCtD
Clofarabine—RRM2—Metabolism—GSTA1—lung cancer	1.65e-05	0.000633	CbGpPWpGaD
Clofarabine—Haemoglobin—Methotrexate—lung cancer	1.64e-05	0.000298	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Paclitaxel—lung cancer	1.64e-05	0.000297	CcSEcCtD
Clofarabine—Fatigue—Paclitaxel—lung cancer	1.64e-05	0.000297	CcSEcCtD
Clofarabine—Haemorrhage—Methotrexate—lung cancer	1.64e-05	0.000296	CcSEcCtD
Clofarabine—DCK—Metabolism—GSTA4—lung cancer	1.64e-05	0.000629	CbGpPWpGaD
Clofarabine—Asthenia—Gemcitabine—lung cancer	1.63e-05	0.000295	CcSEcCtD
Clofarabine—Pain—Paclitaxel—lung cancer	1.63e-05	0.000295	CcSEcCtD
Clofarabine—RRM2—Metabolism—ABCC3—lung cancer	1.63e-05	0.000626	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Methotrexate—lung cancer	1.62e-05	0.000292	CcSEcCtD
Clofarabine—Oedema—Docetaxel—lung cancer	1.61e-05	0.000292	CcSEcCtD
Clofarabine—RRM1—Metabolism—ADCY1—lung cancer	1.61e-05	0.00062	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCG2—lung cancer	1.61e-05	0.00062	CbGpPWpGaD
Clofarabine—Pruritus—Gemcitabine—lung cancer	1.61e-05	0.000291	CcSEcCtD
Clofarabine—Urethral disorder—Methotrexate—lung cancer	1.6e-05	0.00029	CcSEcCtD
Clofarabine—Infection—Docetaxel—lung cancer	1.6e-05	0.00029	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—lung cancer	1.6e-05	0.00029	CcSEcCtD
Clofarabine—Feeling abnormal—Etoposide—lung cancer	1.6e-05	0.000289	CcSEcCtD
Clofarabine—Diarrhoea—Irinotecan—lung cancer	1.6e-05	0.000289	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—lung cancer	1.59e-05	0.000613	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTA2—lung cancer	1.59e-05	0.000613	CbGpPWpGaD
Clofarabine—Pneumonia—Doxorubicin—lung cancer	1.59e-05	0.000287	CcSEcCtD
Clofarabine—Gastrointestinal pain—Etoposide—lung cancer	1.59e-05	0.000287	CcSEcCtD
Clofarabine—Nervous system disorder—Docetaxel—lung cancer	1.58e-05	0.000286	CcSEcCtD
Clofarabine—Thrombocytopenia—Docetaxel—lung cancer	1.58e-05	0.000286	CcSEcCtD
Clofarabine—RRM1—Metabolism—HPGDS—lung cancer	1.58e-05	0.000608	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ENO2—lung cancer	1.58e-05	0.000608	CbGpPWpGaD
Clofarabine—Infestation NOS—Doxorubicin—lung cancer	1.58e-05	0.000286	CcSEcCtD
Clofarabine—Infestation—Doxorubicin—lung cancer	1.58e-05	0.000286	CcSEcCtD
Clofarabine—RRM2—Metabolism—AKR1C1—lung cancer	1.58e-05	0.000606	CbGpPWpGaD
Clofarabine—Tachycardia—Docetaxel—lung cancer	1.57e-05	0.000285	CcSEcCtD
Clofarabine—RRM1—Metabolism—PPP2R1B—lung cancer	1.57e-05	0.000604	CbGpPWpGaD
Clofarabine—Feeling abnormal—Paclitaxel—lung cancer	1.57e-05	0.000284	CcSEcCtD
Clofarabine—Skin disorder—Docetaxel—lung cancer	1.57e-05	0.000284	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	1.56e-05	0.000283	CcSEcCtD
Clofarabine—Hypersensitivity—Cisplatin—lung cancer	1.56e-05	0.000282	CcSEcCtD
Clofarabine—Gastrointestinal pain—Paclitaxel—lung cancer	1.56e-05	0.000282	CcSEcCtD
Clofarabine—Diarrhoea—Gemcitabine—lung cancer	1.56e-05	0.000281	CcSEcCtD
Clofarabine—Renal failure—Doxorubicin—lung cancer	1.55e-05	0.000281	CcSEcCtD
Clofarabine—Erythema multiforme—Methotrexate—lung cancer	1.55e-05	0.00028	CcSEcCtD
Clofarabine—Neuropathy peripheral—Doxorubicin—lung cancer	1.55e-05	0.00028	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.55e-05	0.000595	CbGpPWpGaD
Clofarabine—Dizziness—Irinotecan—lung cancer	1.54e-05	0.000279	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—lung cancer	1.54e-05	0.000278	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—lung cancer	1.54e-05	0.000278	CcSEcCtD
Clofarabine—Anorexia—Docetaxel—lung cancer	1.54e-05	0.000278	CcSEcCtD
Clofarabine—DCK—Metabolism—GSTA1—lung cancer	1.54e-05	0.000591	CbGpPWpGaD
Clofarabine—Abdominal pain—Etoposide—lung cancer	1.53e-05	0.000278	CcSEcCtD
Clofarabine—Body temperature increased—Etoposide—lung cancer	1.53e-05	0.000278	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTT1—lung cancer	1.53e-05	0.000589	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—UGT1A1—lung cancer	1.53e-05	0.000588	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCC3—lung cancer	1.52e-05	0.000585	CbGpPWpGaD
Clofarabine—Asthenia—Cisplatin—lung cancer	1.52e-05	0.000275	CcSEcCtD
Clofarabine—Cardiac disorder—Methotrexate—lung cancer	1.52e-05	0.000275	CcSEcCtD
Clofarabine—RRM1—Metabolism—GCLC—lung cancer	1.51e-05	0.000582	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP2A6—lung cancer	1.51e-05	0.000582	CbGpPWpGaD
Clofarabine—Hypotension—Docetaxel—lung cancer	1.51e-05	0.000273	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.51e-05	0.000579	CbGpPWpGaD
Clofarabine—Haematuria—Doxorubicin—lung cancer	1.51e-05	0.000272	CcSEcCtD
Clofarabine—Body temperature increased—Paclitaxel—lung cancer	1.5e-05	0.000272	CcSEcCtD
Clofarabine—Abdominal pain—Paclitaxel—lung cancer	1.5e-05	0.000272	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.5e-05	0.000578	CbGpPWpGaD
Clofarabine—Hepatobiliary disease—Doxorubicin—lung cancer	1.49e-05	0.00027	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—lung cancer	1.49e-05	0.000269	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.49e-05	0.000572	CbGpPWpGaD
Clofarabine—Angiopathy—Methotrexate—lung cancer	1.48e-05	0.000269	CcSEcCtD
Clofarabine—Vomiting—Irinotecan—lung cancer	1.48e-05	0.000269	CcSEcCtD
Clofarabine—Sinusitis—Doxorubicin—lung cancer	1.48e-05	0.000268	CcSEcCtD
Clofarabine—Immune system disorder—Methotrexate—lung cancer	1.48e-05	0.000268	CcSEcCtD
Clofarabine—RRM2—Metabolism—GNG11—lung cancer	1.47e-05	0.000567	CbGpPWpGaD
Clofarabine—Mediastinal disorder—Methotrexate—lung cancer	1.47e-05	0.000267	CcSEcCtD
Clofarabine—DCK—Metabolism—AKR1C1—lung cancer	1.47e-05	0.000566	CbGpPWpGaD
Clofarabine—Rash—Irinotecan—lung cancer	1.47e-05	0.000266	CcSEcCtD
Clofarabine—Dermatitis—Irinotecan—lung cancer	1.47e-05	0.000266	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Docetaxel—lung cancer	1.47e-05	0.000266	CcSEcCtD
Clofarabine—Chills—Methotrexate—lung cancer	1.47e-05	0.000266	CcSEcCtD
Clofarabine—ABCG2—Metabolism—COL4A3BP—lung cancer	1.47e-05	0.000564	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AZIN2—lung cancer	1.47e-05	0.000564	CbGpPWpGaD
Clofarabine—Headache—Irinotecan—lung cancer	1.46e-05	0.000265	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.46e-05	0.00056	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.45e-05	0.000559	CbGpPWpGaD
Clofarabine—Diarrhoea—Cisplatin—lung cancer	1.45e-05	0.000262	CcSEcCtD
Clofarabine—Paraesthesia—Docetaxel—lung cancer	1.45e-05	0.000262	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—TYMS—lung cancer	1.45e-05	0.000557	CbGpPWpGaD
Clofarabine—Alopecia—Methotrexate—lung cancer	1.45e-05	0.000262	CcSEcCtD
Clofarabine—Vomiting—Gemcitabine—lung cancer	1.45e-05	0.000262	CcSEcCtD
Clofarabine—Dyspnoea—Docetaxel—lung cancer	1.44e-05	0.00026	CcSEcCtD
Clofarabine—RRM1—Metabolism—ENO1—lung cancer	1.44e-05	0.000552	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RB1—lung cancer	1.43e-05	0.000552	CbGpPWpGaD
Clofarabine—Somnolence—Docetaxel—lung cancer	1.43e-05	0.00026	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—lung cancer	1.43e-05	0.000259	CcSEcCtD
Clofarabine—Rash—Gemcitabine—lung cancer	1.43e-05	0.000259	CcSEcCtD
Clofarabine—Dermatitis—Gemcitabine—lung cancer	1.43e-05	0.000259	CcSEcCtD
Clofarabine—Hypersensitivity—Etoposide—lung cancer	1.43e-05	0.000259	CcSEcCtD
Clofarabine—DCK—Metabolism—UGT1A1—lung cancer	1.43e-05	0.00055	CbGpPWpGaD
Clofarabine—Malnutrition—Methotrexate—lung cancer	1.42e-05	0.000258	CcSEcCtD
Clofarabine—Erythema—Methotrexate—lung cancer	1.42e-05	0.000258	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—lung cancer	1.42e-05	0.000258	CcSEcCtD
Clofarabine—Headache—Gemcitabine—lung cancer	1.42e-05	0.000258	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—lung cancer	1.42e-05	0.000256	CcSEcCtD
Clofarabine—RRM2—Metabolism—ALDOA—lung cancer	1.4e-05	0.00054	CbGpPWpGaD
Clofarabine—Decreased appetite—Docetaxel—lung cancer	1.4e-05	0.000254	CcSEcCtD
Clofarabine—Hypersensitivity—Paclitaxel—lung cancer	1.4e-05	0.000254	CcSEcCtD
Clofarabine—Urinary tract disorder—Doxorubicin—lung cancer	1.4e-05	0.000253	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—lung cancer	1.4e-05	0.000253	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Docetaxel—lung cancer	1.39e-05	0.000252	CcSEcCtD
Clofarabine—Asthenia—Etoposide—lung cancer	1.39e-05	0.000252	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—lung cancer	1.39e-05	0.000252	CcSEcCtD
Clofarabine—Fatigue—Docetaxel—lung cancer	1.39e-05	0.000252	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—lung cancer	1.39e-05	0.000251	CcSEcCtD
Clofarabine—Nausea—Irinotecan—lung cancer	1.39e-05	0.000251	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.39e-05	0.000533	CbGpPWpGaD
Clofarabine—Pain—Docetaxel—lung cancer	1.38e-05	0.00025	CcSEcCtD
Clofarabine—DCK—Metabolism—GNG11—lung cancer	1.38e-05	0.00053	CbGpPWpGaD
Clofarabine—Back pain—Methotrexate—lung cancer	1.38e-05	0.000249	CcSEcCtD
Clofarabine—Pruritus—Etoposide—lung cancer	1.37e-05	0.000249	CcSEcCtD
Clofarabine—Asthenia—Paclitaxel—lung cancer	1.37e-05	0.000247	CcSEcCtD
Clofarabine—RRM2—Metabolism—NCOA3—lung cancer	1.36e-05	0.000524	CbGpPWpGaD
Clofarabine—Nausea—Gemcitabine—lung cancer	1.35e-05	0.000244	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.35e-05	0.000518	CbGpPWpGaD
Clofarabine—Vomiting—Cisplatin—lung cancer	1.35e-05	0.000244	CcSEcCtD
Clofarabine—Pruritus—Paclitaxel—lung cancer	1.35e-05	0.000244	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—lung cancer	1.34e-05	0.000242	CcSEcCtD
Clofarabine—Rash—Cisplatin—lung cancer	1.34e-05	0.000242	CcSEcCtD
Clofarabine—Dermatitis—Cisplatin—lung cancer	1.33e-05	0.000242	CcSEcCtD
Clofarabine—Feeling abnormal—Docetaxel—lung cancer	1.33e-05	0.000241	CcSEcCtD
Clofarabine—Diarrhoea—Etoposide—lung cancer	1.33e-05	0.00024	CcSEcCtD
Clofarabine—RRM2—Metabolism—ABCG2—lung cancer	1.33e-05	0.00051	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ADCY1—lung cancer	1.33e-05	0.00051	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Docetaxel—lung cancer	1.32e-05	0.000239	CcSEcCtD
Clofarabine—Anaemia—Methotrexate—lung cancer	1.32e-05	0.000238	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—lung cancer	1.32e-05	0.000238	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—lung cancer	1.32e-05	0.000238	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.31e-05	0.000505	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALDOA—lung cancer	1.31e-05	0.000505	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—RB1—lung cancer	1.31e-05	0.000505	CbGpPWpGaD
Clofarabine—Diarrhoea—Paclitaxel—lung cancer	1.3e-05	0.000236	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—BIRC5—lung cancer	1.3e-05	0.000501	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HPGDS—lung cancer	1.3e-05	0.0005	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ENO2—lung cancer	1.3e-05	0.0005	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCC3—lung cancer	1.3e-05	0.0005	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TYMS—lung cancer	1.29e-05	0.000498	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPP2R1B—lung cancer	1.29e-05	0.000497	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP2E1—lung cancer	1.29e-05	0.000495	CbGpPWpGaD
Clofarabine—Angiopathy—Doxorubicin—lung cancer	1.29e-05	0.000233	CcSEcCtD
Clofarabine—Dizziness—Etoposide—lung cancer	1.28e-05	0.000232	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—RB1—lung cancer	1.28e-05	0.000493	CbGpPWpGaD
Clofarabine—Immune system disorder—Doxorubicin—lung cancer	1.28e-05	0.000232	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—lung cancer	1.28e-05	0.000231	CcSEcCtD
Clofarabine—Body temperature increased—Docetaxel—lung cancer	1.28e-05	0.000231	CcSEcCtD
Clofarabine—Abdominal pain—Docetaxel—lung cancer	1.28e-05	0.000231	CcSEcCtD
Clofarabine—Leukopenia—Methotrexate—lung cancer	1.28e-05	0.000231	CcSEcCtD
Clofarabine—DCK—Metabolism—NCOA3—lung cancer	1.27e-05	0.00049	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NQO1—lung cancer	1.27e-05	0.00049	CbGpPWpGaD
Clofarabine—Chills—Doxorubicin—lung cancer	1.27e-05	0.00023	CcSEcCtD
Clofarabine—RRM2—Metabolism—GSTT1—lung cancer	1.26e-05	0.000485	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—lung cancer	1.26e-05	0.000485	CbGpPWpGaD
Clofarabine—Dizziness—Paclitaxel—lung cancer	1.26e-05	0.000228	CcSEcCtD
Clofarabine—Nausea—Cisplatin—lung cancer	1.26e-05	0.000228	CcSEcCtD
Clofarabine—Alopecia—Doxorubicin—lung cancer	1.25e-05	0.000227	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP2A6—lung cancer	1.25e-05	0.00048	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GCLC—lung cancer	1.25e-05	0.00048	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ATP5H—lung cancer	1.25e-05	0.000479	CbGpPWpGaD
Clofarabine—Cough—Methotrexate—lung cancer	1.24e-05	0.000225	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.24e-05	0.000478	CbGpPWpGaD
Clofarabine—Mental disorder—Doxorubicin—lung cancer	1.24e-05	0.000225	CcSEcCtD
Clofarabine—DCK—Metabolism—ADCY1—lung cancer	1.24e-05	0.000477	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCG2—lung cancer	1.24e-05	0.000477	CbGpPWpGaD
Clofarabine—Vomiting—Etoposide—lung cancer	1.23e-05	0.000223	CcSEcCtD
Clofarabine—Erythema—Doxorubicin—lung cancer	1.23e-05	0.000223	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—lung cancer	1.23e-05	0.000223	CcSEcCtD
Clofarabine—Rash—Etoposide—lung cancer	1.22e-05	0.000221	CcSEcCtD
Clofarabine—Dermatitis—Etoposide—lung cancer	1.22e-05	0.000221	CcSEcCtD
Clofarabine—Headache—Etoposide—lung cancer	1.22e-05	0.00022	CcSEcCtD
Clofarabine—DCK—Metabolism—ENO2—lung cancer	1.22e-05	0.000468	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HPGDS—lung cancer	1.22e-05	0.000468	CbGpPWpGaD
Clofarabine—Arthralgia—Methotrexate—lung cancer	1.21e-05	0.000219	CcSEcCtD
Clofarabine—Myalgia—Methotrexate—lung cancer	1.21e-05	0.000219	CcSEcCtD
Clofarabine—Vomiting—Paclitaxel—lung cancer	1.21e-05	0.000219	CcSEcCtD
Clofarabine—DCK—Metabolism—PPP2R1B—lung cancer	1.21e-05	0.000465	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.21e-05	0.000464	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	1.2e-05	0.000218	CcSEcCtD
Clofarabine—Rash—Paclitaxel—lung cancer	1.2e-05	0.000217	CcSEcCtD
Clofarabine—Dermatitis—Paclitaxel—lung cancer	1.2e-05	0.000217	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—lung cancer	1.19e-05	0.000216	CcSEcCtD
Clofarabine—Headache—Paclitaxel—lung cancer	1.19e-05	0.000216	CcSEcCtD
Clofarabine—Hypersensitivity—Docetaxel—lung cancer	1.19e-05	0.000215	CcSEcCtD
Clofarabine—RRM2—Metabolism—ENO1—lung cancer	1.18e-05	0.000455	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.18e-05	0.000454	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTT1—lung cancer	1.18e-05	0.000453	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—GNG11—lung cancer	1.18e-05	0.000453	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP2A6—lung cancer	1.17e-05	0.000448	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GCLC—lung cancer	1.17e-05	0.000448	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—BIRC5—lung cancer	1.16e-05	0.000448	CbGpPWpGaD
Clofarabine—Asthenia—Docetaxel—lung cancer	1.16e-05	0.000209	CcSEcCtD
Clofarabine—Infection—Methotrexate—lung cancer	1.16e-05	0.000209	CcSEcCtD
Clofarabine—Nausea—Etoposide—lung cancer	1.15e-05	0.000209	CcSEcCtD
Clofarabine—RRM1—Metabolism—STK11—lung cancer	1.15e-05	0.000441	CbGpPWpGaD
Clofarabine—Pruritus—Docetaxel—lung cancer	1.14e-05	0.000207	CcSEcCtD
Clofarabine—Nervous system disorder—Methotrexate—lung cancer	1.14e-05	0.000206	CcSEcCtD
Clofarabine—Anaemia—Doxorubicin—lung cancer	1.14e-05	0.000206	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—lung cancer	1.14e-05	0.000206	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—lung cancer	1.13e-05	0.000205	CcSEcCtD
Clofarabine—Nausea—Paclitaxel—lung cancer	1.13e-05	0.000205	CcSEcCtD
Clofarabine—Skin disorder—Methotrexate—lung cancer	1.13e-05	0.000204	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN2A—lung cancer	1.13e-05	0.000434	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TERT—lung cancer	1.13e-05	0.000434	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Methotrexate—lung cancer	1.12e-05	0.000203	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.12e-05	0.000429	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLBD1—lung cancer	1.11e-05	0.000427	CbGpPWpGaD
Clofarabine—Anorexia—Methotrexate—lung cancer	1.11e-05	0.000201	CcSEcCtD
Clofarabine—DCK—Metabolism—ENO1—lung cancer	1.1e-05	0.000425	CbGpPWpGaD
Clofarabine—Leukopenia—Doxorubicin—lung cancer	1.1e-05	0.0002	CcSEcCtD
Clofarabine—Diarrhoea—Docetaxel—lung cancer	1.1e-05	0.0002	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MDM2—lung cancer	1.09e-05	0.000421	CbGpPWpGaD
Clofarabine—Hypotension—Methotrexate—lung cancer	1.09e-05	0.000197	CcSEcCtD
Clofarabine—Cough—Doxorubicin—lung cancer	1.08e-05	0.000195	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—lung cancer	1.07e-05	0.000412	CbGpPWpGaD
Clofarabine—Dizziness—Docetaxel—lung cancer	1.07e-05	0.000193	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—lung cancer	1.07e-05	0.00041	CbGpPWpGaD
Clofarabine—Hypertension—Doxorubicin—lung cancer	1.06e-05	0.000193	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTP1—lung cancer	1.06e-05	0.000408	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP2E1—lung cancer	1.06e-05	0.000408	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Methotrexate—lung cancer	1.06e-05	0.000192	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ADCY1—lung cancer	1.06e-05	0.000407	CbGpPWpGaD
Clofarabine—Arthralgia—Doxorubicin—lung cancer	1.05e-05	0.00019	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—lung cancer	1.05e-05	0.00019	CcSEcCtD
Clofarabine—RRM2—Metabolism—NQO1—lung cancer	1.05e-05	0.000403	CbGpPWpGaD
Clofarabine—Anxiety—Doxorubicin—lung cancer	1.05e-05	0.000189	CcSEcCtD
Clofarabine—Paraesthesia—Methotrexate—lung cancer	1.04e-05	0.000189	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	1.04e-05	0.000189	CcSEcCtD
Clofarabine—Dyspnoea—Methotrexate—lung cancer	1.04e-05	0.000188	CcSEcCtD
Clofarabine—Somnolence—Methotrexate—lung cancer	1.03e-05	0.000187	CcSEcCtD
Clofarabine—RRM1—Metabolism—CAT—lung cancer	1.03e-05	0.000397	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1A—lung cancer	1.03e-05	0.000396	CbGpPWpGaD
Clofarabine—Vomiting—Docetaxel—lung cancer	1.03e-05	0.000186	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.03e-05	0.000394	CbGpPWpGaD
Clofarabine—Rash—Docetaxel—lung cancer	1.02e-05	0.000184	CcSEcCtD
Clofarabine—Dermatitis—Docetaxel—lung cancer	1.02e-05	0.000184	CcSEcCtD
Clofarabine—ABCG2—Metabolism—HSD17B10—lung cancer	1.02e-05	0.000391	CbGpPWpGaD
Clofarabine—Decreased appetite—Methotrexate—lung cancer	1.01e-05	0.000183	CcSEcCtD
Clofarabine—Headache—Docetaxel—lung cancer	1.01e-05	0.000183	CcSEcCtD
Clofarabine—Oedema—Doxorubicin—lung cancer	1.01e-05	0.000182	CcSEcCtD
Clofarabine—RRM1—Metabolism—ABCB1—lung cancer	1.01e-05	0.000387	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Methotrexate—lung cancer	1e-05	0.000182	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—lung cancer	1e-05	0.000181	CcSEcCtD
Clofarabine—Infection—Doxorubicin—lung cancer	1e-05	0.000181	CcSEcCtD
Clofarabine—Pain—Methotrexate—lung cancer	9.94e-06	0.00018	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	9.92e-06	0.000381	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP2E1—lung cancer	9.91e-06	0.000381	CbGpPWpGaD
Clofarabine—Nervous system disorder—Doxorubicin—lung cancer	9.87e-06	0.000179	CcSEcCtD
Clofarabine—RRM1—Metabolism—TYMS—lung cancer	9.87e-06	0.00038	CbGpPWpGaD
Clofarabine—Thrombocytopenia—Doxorubicin—lung cancer	9.86e-06	0.000178	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TF—lung cancer	9.84e-06	0.000379	CbGpPWpGaD
Clofarabine—Tachycardia—Doxorubicin—lung cancer	9.83e-06	0.000178	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—RB1—lung cancer	9.81e-06	0.000377	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—EP300—lung cancer	9.81e-06	0.000377	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NQO1—lung cancer	9.8e-06	0.000377	CbGpPWpGaD
Clofarabine—Skin disorder—Doxorubicin—lung cancer	9.78e-06	0.000177	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTM1—lung cancer	9.76e-06	0.000375	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Doxorubicin—lung cancer	9.73e-06	0.000176	CcSEcCtD
Clofarabine—Anorexia—Doxorubicin—lung cancer	9.6e-06	0.000174	CcSEcCtD
Clofarabine—Nausea—Docetaxel—lung cancer	9.58e-06	0.000173	CcSEcCtD
Clofarabine—Feeling abnormal—Methotrexate—lung cancer	9.58e-06	0.000173	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCND1—lung cancer	9.53e-06	0.000366	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Methotrexate—lung cancer	9.51e-06	0.000172	CcSEcCtD
Clofarabine—RRM2—Metabolism—STK11—lung cancer	9.45e-06	0.000364	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CKB—lung cancer	9.44e-06	0.000363	CbGpPWpGaD
Clofarabine—Hypotension—Doxorubicin—lung cancer	9.41e-06	0.00017	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP1A1—lung cancer	9.25e-06	0.000356	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1A—lung cancer	9.22e-06	0.000355	CbGpPWpGaD
Clofarabine—Abdominal pain—Methotrexate—lung cancer	9.19e-06	0.000166	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—lung cancer	9.19e-06	0.000166	CcSEcCtD
Clofarabine—RRM1—Metabolism—ERCC2—lung cancer	9.17e-06	0.000353	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.17e-06	0.000166	CcSEcCtD
Clofarabine—Paraesthesia—Doxorubicin—lung cancer	9.04e-06	0.000164	CcSEcCtD
Clofarabine—Dyspnoea—Doxorubicin—lung cancer	8.98e-06	0.000162	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—lung cancer	8.95e-06	0.000162	CcSEcCtD
Clofarabine—ABCG2—Metabolism—GSTM2—lung cancer	8.88e-06	0.000341	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CNDP2—lung cancer	8.88e-06	0.000341	CbGpPWpGaD
Clofarabine—DCK—Metabolism—STK11—lung cancer	8.83e-06	0.00034	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK3—lung cancer	8.79e-06	0.000338	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RB1—lung cancer	8.77e-06	0.000338	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—EP300—lung cancer	8.77e-06	0.000337	CbGpPWpGaD
Clofarabine—Decreased appetite—Doxorubicin—lung cancer	8.75e-06	0.000158	CcSEcCtD
Clofarabine—RRM2—Metabolism—GSTP1—lung cancer	8.74e-06	0.000336	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Doxorubicin—lung cancer	8.69e-06	0.000157	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—lung cancer	8.68e-06	0.000157	CcSEcCtD
Clofarabine—ABCG2—Metabolism—MTMR3—lung cancer	8.64e-06	0.000332	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—lung cancer	8.63e-06	0.000332	CbGpPWpGaD
Clofarabine—Pain—Doxorubicin—lung cancer	8.61e-06	0.000156	CcSEcCtD
Clofarabine—Hypersensitivity—Methotrexate—lung cancer	8.57e-06	0.000155	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—lung cancer	8.55e-06	0.000329	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CAT—lung cancer	8.51e-06	0.000327	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PGAM1—lung cancer	8.42e-06	0.000324	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.37e-06	0.000322	CbGpPWpGaD
Clofarabine—Asthenia—Methotrexate—lung cancer	8.34e-06	0.000151	CcSEcCtD
Clofarabine—Feeling abnormal—Doxorubicin—lung cancer	8.3e-06	0.00015	CcSEcCtD
Clofarabine—RRM2—Metabolism—ABCB1—lung cancer	8.28e-06	0.000318	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Doxorubicin—lung cancer	8.23e-06	0.000149	CcSEcCtD
Clofarabine—Pruritus—Methotrexate—lung cancer	8.23e-06	0.000149	CcSEcCtD
Clofarabine—DCK—Metabolism—GSTP1—lung cancer	8.17e-06	0.000314	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TYMS—lung cancer	8.13e-06	0.000313	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—lung cancer	8.04e-06	0.000309	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTM1—lung cancer	8.03e-06	0.000309	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2A7—lung cancer	8.03e-06	0.000309	CbGpPWpGaD
Clofarabine—Body temperature increased—Doxorubicin—lung cancer	7.96e-06	0.000144	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—lung cancer	7.96e-06	0.000144	CcSEcCtD
Clofarabine—Diarrhoea—Methotrexate—lung cancer	7.95e-06	0.000144	CcSEcCtD
Clofarabine—DCK—Metabolism—CAT—lung cancer	7.95e-06	0.000306	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOA1—lung cancer	7.94e-06	0.000305	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK3—lung cancer	7.86e-06	0.000302	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SDC4—lung cancer	7.86e-06	0.000302	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCB1—lung cancer	7.73e-06	0.000298	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2A—lung cancer	7.71e-06	0.000297	CbGpPWpGaD
Clofarabine—Dizziness—Methotrexate—lung cancer	7.69e-06	0.000139	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MYC—lung cancer	7.64e-06	0.000294	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1A1—lung cancer	7.62e-06	0.000293	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TYMS—lung cancer	7.6e-06	0.000292	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ERCC2—lung cancer	7.55e-06	0.000291	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTM1—lung cancer	7.51e-06	0.000289	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MDM2—lung cancer	7.48e-06	0.000288	CbGpPWpGaD
Clofarabine—Hypersensitivity—Doxorubicin—lung cancer	7.42e-06	0.000134	CcSEcCtD
Clofarabine—Vomiting—Methotrexate—lung cancer	7.39e-06	0.000134	CcSEcCtD
Clofarabine—Rash—Methotrexate—lung cancer	7.33e-06	0.000133	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—lung cancer	7.32e-06	0.000133	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—lung cancer	7.29e-06	0.00028	CbGpPWpGaD
Clofarabine—Headache—Methotrexate—lung cancer	7.28e-06	0.000132	CcSEcCtD
Clofarabine—RRM1—Metabolism—PIK3CG—lung cancer	7.25e-06	0.000279	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—lung cancer	7.22e-06	0.000131	CcSEcCtD
Clofarabine—ABCG2—Metabolism—RRM1—lung cancer	7.16e-06	0.000275	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA3—lung cancer	7.16e-06	0.000275	CbGpPWpGaD
Clofarabine—Pruritus—Doxorubicin—lung cancer	7.12e-06	0.000129	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP1A1—lung cancer	7.12e-06	0.000274	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ERCC2—lung cancer	7.06e-06	0.000272	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—lung cancer	7.05e-06	0.000271	CbGpPWpGaD
Clofarabine—Nausea—Methotrexate—lung cancer	6.91e-06	0.000125	CcSEcCtD
Clofarabine—RRM1—Metabolism—POMC—lung cancer	6.9e-06	0.000265	CbGpPWpGaD
Clofarabine—Diarrhoea—Doxorubicin—lung cancer	6.89e-06	0.000125	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—AVP—lung cancer	6.82e-06	0.000262	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—B4GALT5—lung cancer	6.73e-06	0.000259	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CREBBP—lung cancer	6.72e-06	0.000258	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—EP300—lung cancer	6.71e-06	0.000258	CbGpPWpGaD
Clofarabine—Dizziness—Doxorubicin—lung cancer	6.66e-06	0.00012	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCB1—lung cancer	6.61e-06	0.000254	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA4—lung cancer	6.54e-06	0.000252	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOA1—lung cancer	6.54e-06	0.000251	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—lung cancer	6.52e-06	0.000251	CbGpPWpGaD
Clofarabine—Vomiting—Doxorubicin—lung cancer	6.4e-06	0.000116	CcSEcCtD
Clofarabine—ABCG2—Metabolism—GSTA2—lung cancer	6.38e-06	0.000245	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CD—lung cancer	6.37e-06	0.000245	CbGpPWpGaD
Clofarabine—Rash—Doxorubicin—lung cancer	6.35e-06	0.000115	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—lung cancer	6.34e-06	0.000115	CcSEcCtD
Clofarabine—Headache—Doxorubicin—lung cancer	6.31e-06	0.000114	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDKN1A—lung cancer	6.3e-06	0.000242	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALB—lung cancer	6.29e-06	0.000242	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—lung cancer	6.28e-06	0.000241	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA1—lung cancer	6.15e-06	0.000237	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOA1—lung cancer	6.11e-06	0.000235	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCC3—lung cancer	6.08e-06	0.000234	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK3—lung cancer	6.01e-06	0.000231	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—EP300—lung cancer	6e-06	0.000231	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—lung cancer	5.98e-06	0.000108	CcSEcCtD
Clofarabine—RRM2—Metabolism—PIK3CG—lung cancer	5.97e-06	0.00023	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKR1C1—lung cancer	5.89e-06	0.000227	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—lung cancer	5.85e-06	0.000225	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—UGT1A1—lung cancer	5.72e-06	0.00022	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—POMC—lung cancer	5.68e-06	0.000218	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—lung cancer	5.58e-06	0.000214	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CB—lung cancer	5.55e-06	0.000214	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CREBBP—lung cancer	5.53e-06	0.000213	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GNG11—lung cancer	5.52e-06	0.000212	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—lung cancer	5.5e-06	0.000212	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK3—lung cancer	5.37e-06	0.000207	CbGpPWpGaD
Clofarabine—DCK—Metabolism—POMC—lung cancer	5.31e-06	0.000204	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALDOA—lung cancer	5.25e-06	0.000202	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CD—lung cancer	5.24e-06	0.000202	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—lung cancer	5.23e-06	0.000201	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—APOA1—lung cancer	5.22e-06	0.000201	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALB—lung cancer	5.18e-06	0.000199	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CREBBP—lung cancer	5.17e-06	0.000199	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOA3—lung cancer	5.1e-06	0.000196	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ADCY1—lung cancer	4.96e-06	0.000191	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CD—lung cancer	4.9e-06	0.000189	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ENO2—lung cancer	4.86e-06	0.000187	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HPGDS—lung cancer	4.86e-06	0.000187	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALB—lung cancer	4.84e-06	0.000186	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPP2R1B—lung cancer	4.83e-06	0.000186	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—lung cancer	4.8e-06	0.000185	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTT1—lung cancer	4.72e-06	0.000181	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GCLC—lung cancer	4.66e-06	0.000179	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2A6—lung cancer	4.66e-06	0.000179	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—EP300—lung cancer	4.57e-06	0.000176	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CB—lung cancer	4.57e-06	0.000176	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—lung cancer	4.53e-06	0.000174	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ENO1—lung cancer	4.42e-06	0.00017	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—CREBBP—lung cancer	4.42e-06	0.00017	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—lung cancer	4.29e-06	0.000165	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CB—lung cancer	4.27e-06	0.000164	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—lung cancer	4.23e-06	0.000163	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ALB—lung cancer	4.13e-06	0.000159	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2E1—lung cancer	3.96e-06	0.000153	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—lung cancer	3.95e-06	0.000152	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NQO1—lung cancer	3.92e-06	0.000151	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—EP300—lung cancer	3.77e-06	0.000145	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—RAF1—lung cancer	3.74e-06	0.000144	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—lung cancer	3.69e-06	0.000142	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—STK11—lung cancer	3.53e-06	0.000136	CbGpPWpGaD
Clofarabine—DCK—Metabolism—EP300—lung cancer	3.52e-06	0.000135	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—lung cancer	3.38e-06	0.00013	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTP1—lung cancer	3.27e-06	0.000126	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CAT—lung cancer	3.18e-06	0.000122	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCB1—lung cancer	3.1e-06	0.000119	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TYMS—lung cancer	3.04e-06	0.000117	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM1—lung cancer	3e-06	0.000116	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1A1—lung cancer	2.85e-06	0.00011	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ERCC2—lung cancer	2.83e-06	0.000109	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—lung cancer	2.79e-06	0.000107	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—lung cancer	2.76e-06	0.000106	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—lung cancer	2.6e-06	0.0001	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOA1—lung cancer	2.44e-06	9.4e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—lung cancer	2.28e-06	8.76e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—lung cancer	2.23e-06	8.58e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—lung cancer	2.13e-06	8.18e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—POMC—lung cancer	2.12e-06	8.17e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CREBBP—lung cancer	2.07e-06	7.96e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CD—lung cancer	1.96e-06	7.55e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALB—lung cancer	1.94e-06	7.45e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CB—lung cancer	1.71e-06	6.58e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—lung cancer	1.69e-06	6.52e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—lung cancer	1.48e-06	5.68e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—EP300—lung cancer	1.41e-06	5.42e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—lung cancer	1.04e-06	4.01e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—lung cancer	8.51e-07	3.28e-05	CbGpPWpGaD
